0.03% 0.0037

Amicus Therapeutics Inc (FOLD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt FOLD? Forum Prognose

Finanzdaten der Amicus Therapeutics Inc-Aktie (FOLD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	9.55% 185.21	169.06	154.69	125.25	141.52
Cost Of Revenue	36.37% 26.55	19.47	15.22	11.70	13.28
Gross Profit	6.06% 158.66	149.59	139.47	113.55	128.24
Operating Expenses	23.75% 142.72	115.33	148.94	121.50	106.58
Benefits Costs and Expenses	35.08% 182.07	134.79	173.87	143.29	134.73
Costs And Expenses	35.08% 182.07	134.79	173.87	143.29	134.73
Operating Income/Loss	53.47% 15.95	34.27	-9.474	-7.952	21.66
Income/Loss From Continuing Operations Before Tax	90.83% 3.143	34.27	-19.18	-18.05	6.785
Income Tax Expense/Benefit	91.44% 1.453	16.97	5.239	3.641	13.51
Income/Loss From Continuing Operations After Tax	90.23% 1.69	17.31	-24.42	-21.69	-6.729
Net Income/Loss	90.23% 1.69	17.31	-24.42	-21.69	-6.729
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.93% 0.2246	308.47	308.25	307.69	304.69
Diluted Average Shares	99.93% 0.2246	310.43	308.25	307.69	304.69
Basic Earnings Per Share	100.00% -	0.06	-0.08	-0.07	-0.02
Diluted Earnings Per Share	100.00% -	0.06	-0.08	-0.07	-0.02
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%